Filing Flows › Organon (OGN) › Q1 2026
Organon (OGN) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 4, 2026
Organon (OGN) reported revenue of $1.5B for the first quarter 2026 (Q1 2026), -4% from a year earlier and -3% from the quarter before. Operating margin was 14.6%, net earnings $146M (10.0% of revenue).
Organon, Q1 2026: revenue $1.5B (-4% year over year), operating margin 14.6%, net earnings $146M, operating cash flow $225M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5B | -3% | -4% |
| Gross profit | $783M | +6% | -7% |
| Operating profit | $213M | — | +111% |
| Net earnings | $146M | — | +68% |
| Operating cash flow | $225M | +60% | +200% |
| Free cash flow | $188M | +96% | +337% |
What changed
Revenue was $1.5B in Q1 2026, down 4% year over year and down 3% from the previous quarter.
Gross margin was 53.6%, down 2.0 points from Q1 2025. Operating profit was $0.21B, a 14.6% margin (up 7.9 points year over year). Operating expenses fell 23% while revenue fell 4%. Net earnings were $0.15B, up 68% year over year. The effective tax rate was 31.5%.
Operating cash flow was $0.23B (up 200% year over year), 154% of net earnings. Non-cash charges added back $0.04B of depreciation and $0.02B of share-based compensation. Working capital and other items added $0.02B. Capital expenditures of $0.04B left free cash flow of $0.19B.
Questions
What was Organon's revenue in the first quarter 2026?
Organon (OGN) reported revenue of $1.5B for the first quarter 2026 (Q1 2026), -4% from a year earlier and -3% from the quarter before.
Was Organon profitable in the first quarter 2026?
Operating profit was $213M (14.6% of revenue) and net earnings $146M.
Source: Organon 10-Q on SEC EDGAR.